Log In
Print
BCIQ
Print
Print this Print this
 

Caripul, Epoprostenol ACT, Veletri, epoprostenol

  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionIntravenous prostacyclin analog
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH); Treat severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today